Manned space missions recently increased in number and duration, thus it be
came important to estimate the biological risks encountered by astronauts.
They are exposed to cosmic and galactic rays, a complex mixture of differen
t radiations. In addition to the measurements realized by physical dosimete
rs, it becomes essential to estimate real biologically effective doses and
compare them to physical doses. Biological dosimetry of radiation exposures
has been widely performed using cytogenetic analysis of chromosomes. This
approach has been used for many years in order to estimate absorbed doses i
n accidental or chronic overexposures of humans. In addition to conventiona
l techniques (Giemsa or FPG staining, R- or G-banding), faster and accurate
means of analysis have been developed (fluorescence in situ hybridization
[FISH] painting). As results accumulate, it appears that strong interindivi
dual variability exists in the basal level of aberrations. Moreover, some a
berrations such as translocations exhibit a high background level. Radiatio
n exposures seem to induce variability between individual responses. Its ex
tent strongly differs with the mode of exposure, the doses delivered, the k
ind of radiation, and the cytogenetic method used. This paper aims to revie
w the factors that may influence the reliability of cytogenetic dosimetry.
The emphasis is on the exposure to high linear energy transfer (LET) partic
les in space as recent studies demonstrated interindividual variations in d
oses estimated from aberration analysis after long-term space missions. In
addition to the problem of dose estimates, the heterogeneity of cosmic radi
ation raises questions relating to the real numbers of damaged cells in an
individual, and potential long-term risks. Actually, densely ionizing parti
cles are extremely potent to induce late chromosomal instability, and again
, interindividual variability exists in the expression of damage. (C) 1999
Elsevier Science B.V. All rights reserved.